Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
Erectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of actio...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2001
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf |
| _version_ | 1797009686671654912 |
|---|---|
| author | Doshi, Sanjay Lalitchandra |
| author_facet | Doshi, Sanjay Lalitchandra |
| author_sort | Doshi, Sanjay Lalitchandra |
| collection | USM |
| description | Erectile dysfunction is a common complication of Diabetes Mellitus.
Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has
been used successfully in the treatment of erectile dysfunction. Results with
Alprostadil have shown a poorer response, shorter duration of action and need
for higher dosage in diabetic patients with erectile dysfunction when compared
to the general population. No study targeted specifically to the diabetic
population has been completed with Alprostadil so far. |
| first_indexed | 2024-03-06T15:09:04Z |
| format | Thesis |
| id | usm.eprints-36699 |
| institution | Universiti Sains Malaysia |
| language | English |
| last_indexed | 2024-03-06T15:09:04Z |
| publishDate | 2001 |
| record_format | dspace |
| spelling | usm.eprints-366992019-04-12T05:27:05Z http://eprints.usm.my/36699/ Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction Doshi, Sanjay Lalitchandra RC31-1245 Internal medicine Erectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of action and need for higher dosage in diabetic patients with erectile dysfunction when compared to the general population. No study targeted specifically to the diabetic population has been completed with Alprostadil so far. 2001 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf Doshi, Sanjay Lalitchandra (2001) Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction. Masters thesis, Universiti Sains Malaysia. |
| spellingShingle | RC31-1245 Internal medicine Doshi, Sanjay Lalitchandra Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction |
| title | Efficacy and Safety of Intracavernosal Alprostadil
in Diabetic Patients with Erectile Dysfunction |
| title_full | Efficacy and Safety of Intracavernosal Alprostadil
in Diabetic Patients with Erectile Dysfunction |
| title_fullStr | Efficacy and Safety of Intracavernosal Alprostadil
in Diabetic Patients with Erectile Dysfunction |
| title_full_unstemmed | Efficacy and Safety of Intracavernosal Alprostadil
in Diabetic Patients with Erectile Dysfunction |
| title_short | Efficacy and Safety of Intracavernosal Alprostadil
in Diabetic Patients with Erectile Dysfunction |
| title_sort | efficacy and safety of intracavernosal alprostadil in diabetic patients with erectile dysfunction |
| topic | RC31-1245 Internal medicine |
| url | http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf |
| work_keys_str_mv | AT doshisanjaylalitchandra efficacyandsafetyofintracavernosalalprostadilindiabeticpatientswitherectiledysfunction |